Ontology type: schema:Chapter
2020-07-01
AUTHORSVolker Ziller , Petra Stute , Michael von Wolff
ABSTRACTThis chapter describes causes, diagnostic and therapeutic procedures in the event of premature ovarian insufficiency (POI) induced either by gonadotoxic treatments or caused by genetic defects, autoimmunological disease, infection, surgical interventions, etc. POI is defined by oligo-/amenorrhea for at least 4 months and a serum concentration of FSH > 25 IU/I measured twice at least 4 weeks apart in women before the age of 40 years. Women with POI generally show the typical symptoms of menopause such as cycle disorders, hot flushes, vaginal dryness, sleep disorders and psychological changes such as nervousness, irritability, fatigue and others. Fertility of POI patients is severely reduced and total infertility can occur. The lack of estrogen leads to considerable long-term consequences. These are primarily effects on bone metabolism, the cardiovascular system and changes in the nervous system that result in a reduced life expectancy. The misinterpretation of the WHI (Women’s Health Initiative) study has led to an irrational fear of hormone replacement therapy (HRT) for both patients and doctors. However, with the increased risk associated with POI/early menopause HRT is advantageous if the oncological and other contraindications to HRT are followed. The risks of non-HRT must therefore be weighed individually against the risks of HRT. More... »
PAGES273-282
Fertility Preservation in Oncological and Non-Oncological Diseases
ISBN
978-3-030-47567-3
978-3-030-47568-0
http://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_31
DOIhttp://dx.doi.org/10.1007/978-3-030-47568-0_31
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1128877367
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1114",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Paediatrics and Reproductive Medicine",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Dep. Gyn. Endocrinology and Reproductive Medicine, Clinic for Gynaecology and Obstetrics, University Hospital Giessen and Marburg (UKGM), Marburg, Germany",
"id": "http://www.grid.ac/institutes/grid.411067.5",
"name": [
"Dep. Gyn. Endocrinology and Reproductive Medicine, Clinic for Gynaecology and Obstetrics, University Hospital Giessen and Marburg (UKGM), Marburg, Germany"
],
"type": "Organization"
},
"familyName": "Ziller",
"givenName": "Volker",
"id": "sg:person.01157414011.31",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157414011.31"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, University of Bern, Bern, Switzerland",
"id": "http://www.grid.ac/institutes/grid.411656.1",
"name": [
"Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, University of Bern, Bern, Switzerland"
],
"type": "Organization"
},
"familyName": "Stute",
"givenName": "Petra",
"id": "sg:person.01266270133.70",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266270133.70"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, University of Bern, Bern, Switzerland",
"id": "http://www.grid.ac/institutes/grid.411656.1",
"name": [
"Division of Gynaecological Endocrinology and Reproductive Medicine, University Women\u2019s Hospital, University of Bern, Bern, Switzerland"
],
"type": "Organization"
},
"familyName": "von Wolff",
"givenName": "Michael",
"id": "sg:person.0610777233.66",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610777233.66"
],
"type": "Person"
}
],
"datePublished": "2020-07-01",
"datePublishedReg": "2020-07-01",
"description": "This chapter describes causes, diagnostic and therapeutic procedures in the event of premature ovarian insufficiency (POI) induced either by gonadotoxic treatments or caused by genetic defects, autoimmunological disease, infection, surgical interventions, etc. POI is defined by oligo-/amenorrhea for at least 4\u00a0months and a serum concentration of FSH\u00a0>\u00a025\u00a0IU/I measured twice at least 4\u00a0weeks apart in women before the age of 40\u00a0years. Women with POI generally show the typical symptoms of menopause such as cycle disorders, hot flushes, vaginal dryness, sleep disorders and psychological changes such as nervousness, irritability, fatigue and others. Fertility of POI patients is severely reduced and total infertility can occur. The lack of estrogen leads to considerable long-term consequences. These are primarily effects on bone metabolism, the cardiovascular system and changes in the nervous system that result in a reduced life expectancy. The misinterpretation of the WHI (Women\u2019s Health Initiative) study has led to an irrational fear of hormone replacement therapy (HRT) for both patients and doctors. However, with the increased risk associated with POI/early menopause HRT is advantageous if the oncological and other contraindications to HRT are followed. The risks of non-HRT must therefore be weighed individually against the risks of HRT.",
"editor": [
{
"familyName": "von Wolff",
"givenName": "Michael",
"type": "Person"
},
{
"familyName": "Nawroth",
"givenName": "Frank",
"type": "Person"
}
],
"genre": "chapter",
"id": "sg:pub.10.1007/978-3-030-47568-0_31",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": {
"isbn": [
"978-3-030-47567-3",
"978-3-030-47568-0"
],
"name": "Fertility Preservation in Oncological and Non-Oncological Diseases",
"type": "Book"
},
"keywords": [
"hormone replacement therapy",
"premature ovarian insufficiency",
"replacement therapy",
"risks of HRT",
"menopause hormone replacement therapy",
"lack of estrogen",
"reduced life expectancy",
"hot flushes",
"vaginal dryness",
"WHI study",
"gonadotoxic treatment",
"surgical intervention",
"POI patients",
"serum concentrations",
"bone metabolism",
"Follow-up",
"autoimmunological diseases",
"ovarian insufficiency",
"sleep disorders",
"long-term consequences",
"therapeutic procedures",
"nervous system",
"cycle disorders",
"cardiovascular system",
"total infertility",
"typical symptoms",
"life expectancy",
"genetic defects",
"patients",
"therapy",
"risk",
"women",
"disorders",
"psychological changes",
"irrational fear",
"contraindications",
"menopause",
"FSH",
"infertility",
"estrogen",
"insufficiency",
"symptoms",
"infection",
"irritability",
"disease",
"IU",
"weeks",
"months",
"intervention",
"age",
"treatment",
"doctors",
"cause",
"metabolism",
"nervousness",
"expectancy",
"dryness",
"fatigue",
"changes",
"flushes",
"years",
"fertility",
"study",
"fear",
"events",
"lack",
"defects",
"procedure",
"effect",
"concentration",
"misinterpretation",
"consequences",
"system",
"chapter"
],
"name": "Premature Ovarian Insufficiency: Hormone Replacement Therapy and Follow-Up",
"pagination": "273-282",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1128877367"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/978-3-030-47568-0_31"
]
}
],
"publisher": {
"name": "Springer Nature",
"type": "Organisation"
},
"sameAs": [
"https://doi.org/10.1007/978-3-030-47568-0_31",
"https://app.dimensions.ai/details/publication/pub.1128877367"
],
"sdDataset": "chapters",
"sdDatePublished": "2022-06-01T22:31",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/chapter/chapter_290.jsonl",
"type": "Chapter",
"url": "https://doi.org/10.1007/978-3-030-47568-0_31"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_31'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_31'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_31'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-030-47568-0_31'
This table displays all metadata directly associated to this object as RDF triples.
160 TRIPLES
23 PREDICATES
99 URIs
91 LITERALS
7 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/978-3-030-47568-0_31 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1103 |
3 | ″ | ″ | anzsrc-for:1114 |
4 | ″ | schema:author | N08712dd9844b442c98c0e6d15b3d8dc5 |
5 | ″ | schema:datePublished | 2020-07-01 |
6 | ″ | schema:datePublishedReg | 2020-07-01 |
7 | ″ | schema:description | This chapter describes causes, diagnostic and therapeutic procedures in the event of premature ovarian insufficiency (POI) induced either by gonadotoxic treatments or caused by genetic defects, autoimmunological disease, infection, surgical interventions, etc. POI is defined by oligo-/amenorrhea for at least 4 months and a serum concentration of FSH > 25 IU/I measured twice at least 4 weeks apart in women before the age of 40 years. Women with POI generally show the typical symptoms of menopause such as cycle disorders, hot flushes, vaginal dryness, sleep disorders and psychological changes such as nervousness, irritability, fatigue and others. Fertility of POI patients is severely reduced and total infertility can occur. The lack of estrogen leads to considerable long-term consequences. These are primarily effects on bone metabolism, the cardiovascular system and changes in the nervous system that result in a reduced life expectancy. The misinterpretation of the WHI (Women’s Health Initiative) study has led to an irrational fear of hormone replacement therapy (HRT) for both patients and doctors. However, with the increased risk associated with POI/early menopause HRT is advantageous if the oncological and other contraindications to HRT are followed. The risks of non-HRT must therefore be weighed individually against the risks of HRT. |
8 | ″ | schema:editor | Ne2b044c011c44d61a9a7e481aec825f0 |
9 | ″ | schema:genre | chapter |
10 | ″ | schema:inLanguage | en |
11 | ″ | schema:isAccessibleForFree | false |
12 | ″ | schema:isPartOf | Ndb836c57a4644f2c9e6a72b993dda80a |
13 | ″ | schema:keywords | FSH |
14 | ″ | ″ | Follow-up |
15 | ″ | ″ | IU |
16 | ″ | ″ | POI patients |
17 | ″ | ″ | WHI study |
18 | ″ | ″ | age |
19 | ″ | ″ | autoimmunological diseases |
20 | ″ | ″ | bone metabolism |
21 | ″ | ″ | cardiovascular system |
22 | ″ | ″ | cause |
23 | ″ | ″ | changes |
24 | ″ | ″ | chapter |
25 | ″ | ″ | concentration |
26 | ″ | ″ | consequences |
27 | ″ | ″ | contraindications |
28 | ″ | ″ | cycle disorders |
29 | ″ | ″ | defects |
30 | ″ | ″ | disease |
31 | ″ | ″ | disorders |
32 | ″ | ″ | doctors |
33 | ″ | ″ | dryness |
34 | ″ | ″ | effect |
35 | ″ | ″ | estrogen |
36 | ″ | ″ | events |
37 | ″ | ″ | expectancy |
38 | ″ | ″ | fatigue |
39 | ″ | ″ | fear |
40 | ″ | ″ | fertility |
41 | ″ | ″ | flushes |
42 | ″ | ″ | genetic defects |
43 | ″ | ″ | gonadotoxic treatment |
44 | ″ | ″ | hormone replacement therapy |
45 | ″ | ″ | hot flushes |
46 | ″ | ″ | infection |
47 | ″ | ″ | infertility |
48 | ″ | ″ | insufficiency |
49 | ″ | ″ | intervention |
50 | ″ | ″ | irrational fear |
51 | ″ | ″ | irritability |
52 | ″ | ″ | lack |
53 | ″ | ″ | lack of estrogen |
54 | ″ | ″ | life expectancy |
55 | ″ | ″ | long-term consequences |
56 | ″ | ″ | menopause |
57 | ″ | ″ | menopause hormone replacement therapy |
58 | ″ | ″ | metabolism |
59 | ″ | ″ | misinterpretation |
60 | ″ | ″ | months |
61 | ″ | ″ | nervous system |
62 | ″ | ″ | nervousness |
63 | ″ | ″ | ovarian insufficiency |
64 | ″ | ″ | patients |
65 | ″ | ″ | premature ovarian insufficiency |
66 | ″ | ″ | procedure |
67 | ″ | ″ | psychological changes |
68 | ″ | ″ | reduced life expectancy |
69 | ″ | ″ | replacement therapy |
70 | ″ | ″ | risk |
71 | ″ | ″ | risks of HRT |
72 | ″ | ″ | serum concentrations |
73 | ″ | ″ | sleep disorders |
74 | ″ | ″ | study |
75 | ″ | ″ | surgical intervention |
76 | ″ | ″ | symptoms |
77 | ″ | ″ | system |
78 | ″ | ″ | therapeutic procedures |
79 | ″ | ″ | therapy |
80 | ″ | ″ | total infertility |
81 | ″ | ″ | treatment |
82 | ″ | ″ | typical symptoms |
83 | ″ | ″ | vaginal dryness |
84 | ″ | ″ | weeks |
85 | ″ | ″ | women |
86 | ″ | ″ | years |
87 | ″ | schema:name | Premature Ovarian Insufficiency: Hormone Replacement Therapy and Follow-Up |
88 | ″ | schema:pagination | 273-282 |
89 | ″ | schema:productId | N9ec705d5604e4877970cc4a97eaafbf8 |
90 | ″ | ″ | Nabfab15b2f1a438291cadde43157dc81 |
91 | ″ | schema:publisher | N72886ec4b2ce414ca3d6afd79d2c2dbf |
92 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1128877367 |
93 | ″ | ″ | https://doi.org/10.1007/978-3-030-47568-0_31 |
94 | ″ | schema:sdDatePublished | 2022-06-01T22:31 |
95 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
96 | ″ | schema:sdPublisher | N771a17ede44646b99d560ad2f974dfd4 |
97 | ″ | schema:url | https://doi.org/10.1007/978-3-030-47568-0_31 |
98 | ″ | sgo:license | sg:explorer/license/ |
99 | ″ | sgo:sdDataset | chapters |
100 | ″ | rdf:type | schema:Chapter |
101 | N08712dd9844b442c98c0e6d15b3d8dc5 | rdf:first | sg:person.01157414011.31 |
102 | ″ | rdf:rest | N0a2e4e02ad8246d39eacaf2ab39e421d |
103 | N0a2e4e02ad8246d39eacaf2ab39e421d | rdf:first | sg:person.01266270133.70 |
104 | ″ | rdf:rest | N98288a3be3a04e579de6ba212f9912f9 |
105 | N6a27de6e40164e4ca50a398077281e32 | rdf:first | Ne58f880deeb9414c826bab3a5bbd6aa1 |
106 | ″ | rdf:rest | rdf:nil |
107 | N72886ec4b2ce414ca3d6afd79d2c2dbf | schema:name | Springer Nature |
108 | ″ | rdf:type | schema:Organisation |
109 | N771a17ede44646b99d560ad2f974dfd4 | schema:name | Springer Nature - SN SciGraph project |
110 | ″ | rdf:type | schema:Organization |
111 | N7f554944d63e4a2496640ab2ab70e195 | schema:familyName | von Wolff |
112 | ″ | schema:givenName | Michael |
113 | ″ | rdf:type | schema:Person |
114 | N98288a3be3a04e579de6ba212f9912f9 | rdf:first | sg:person.0610777233.66 |
115 | ″ | rdf:rest | rdf:nil |
116 | N9ec705d5604e4877970cc4a97eaafbf8 | schema:name | dimensions_id |
117 | ″ | schema:value | pub.1128877367 |
118 | ″ | rdf:type | schema:PropertyValue |
119 | Nabfab15b2f1a438291cadde43157dc81 | schema:name | doi |
120 | ″ | schema:value | 10.1007/978-3-030-47568-0_31 |
121 | ″ | rdf:type | schema:PropertyValue |
122 | Ndb836c57a4644f2c9e6a72b993dda80a | schema:isbn | 978-3-030-47567-3 |
123 | ″ | ″ | 978-3-030-47568-0 |
124 | ″ | schema:name | Fertility Preservation in Oncological and Non-Oncological Diseases |
125 | ″ | rdf:type | schema:Book |
126 | Ne2b044c011c44d61a9a7e481aec825f0 | rdf:first | N7f554944d63e4a2496640ab2ab70e195 |
127 | ″ | rdf:rest | N6a27de6e40164e4ca50a398077281e32 |
128 | Ne58f880deeb9414c826bab3a5bbd6aa1 | schema:familyName | Nawroth |
129 | ″ | schema:givenName | Frank |
130 | ″ | rdf:type | schema:Person |
131 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
132 | ″ | schema:name | Medical and Health Sciences |
133 | ″ | rdf:type | schema:DefinedTerm |
134 | anzsrc-for:1103 | schema:inDefinedTermSet | anzsrc-for: |
135 | ″ | schema:name | Clinical Sciences |
136 | ″ | rdf:type | schema:DefinedTerm |
137 | anzsrc-for:1114 | schema:inDefinedTermSet | anzsrc-for: |
138 | ″ | schema:name | Paediatrics and Reproductive Medicine |
139 | ″ | rdf:type | schema:DefinedTerm |
140 | sg:person.01157414011.31 | schema:affiliation | grid-institutes:grid.411067.5 |
141 | ″ | schema:familyName | Ziller |
142 | ″ | schema:givenName | Volker |
143 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157414011.31 |
144 | ″ | rdf:type | schema:Person |
145 | sg:person.01266270133.70 | schema:affiliation | grid-institutes:grid.411656.1 |
146 | ″ | schema:familyName | Stute |
147 | ″ | schema:givenName | Petra |
148 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266270133.70 |
149 | ″ | rdf:type | schema:Person |
150 | sg:person.0610777233.66 | schema:affiliation | grid-institutes:grid.411656.1 |
151 | ″ | schema:familyName | von Wolff |
152 | ″ | schema:givenName | Michael |
153 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610777233.66 |
154 | ″ | rdf:type | schema:Person |
155 | grid-institutes:grid.411067.5 | schema:alternateName | Dep. Gyn. Endocrinology and Reproductive Medicine, Clinic for Gynaecology and Obstetrics, University Hospital Giessen and Marburg (UKGM), Marburg, Germany |
156 | ″ | schema:name | Dep. Gyn. Endocrinology and Reproductive Medicine, Clinic for Gynaecology and Obstetrics, University Hospital Giessen and Marburg (UKGM), Marburg, Germany |
157 | ″ | rdf:type | schema:Organization |
158 | grid-institutes:grid.411656.1 | schema:alternateName | Division of Gynaecological Endocrinology and Reproductive Medicine, University Women’s Hospital, University of Bern, Bern, Switzerland |
159 | ″ | schema:name | Division of Gynaecological Endocrinology and Reproductive Medicine, University Women’s Hospital, University of Bern, Bern, Switzerland |
160 | ″ | rdf:type | schema:Organization |